Brown Morgan L, McKellar Stephen H, Sundt Thoralf M, Schaff Hartzell V
Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
J Thorac Cardiovasc Surg. 2009 Mar;137(3):670-679.e5. doi: 10.1016/j.jtcvs.2008.08.010. Epub 2008 Oct 23.
Most aortic valve replacements are by conventional full median sternotomy. Less invasive approaches have been developed with partial upper sternotomy (ministernotomy).
Systematic review and meta-analysis were performed with studies comparing ministernotomy and full sternotomy for aortic valve replacement.
Twenty-six studies were selected, with 4586 patients with aortic valve replacement (2054 ministernotomy, 2532 full sternotomy). There was no difference in mortality (odds ratio 0.71, 95% confidence interval 0.49-1.02). Ministernotomy had longer crossclamp and bypass times (weighted mean difference 7.90 minutes, 95% confidence interval 3.50-10.29 minutes, and 11.46 minutes, 95% confidence interval 5.26-17.65 minutes, respectively). Both intensive care unit and hospital stays were shorter with ministernotomy (weighted mean difference -0.46 days, 95% confidence interval -0.72 to -0.20 days, and -0.91 days, 95% confidence interval -1.45 to -0.37 days, respectively). Ministernotomy had shorter ventilation time and less blood loss within 24 hours (weighted mean difference -2.1 hours, 95% confidence interval -2.95 to -1.30 hours, and -79 mL, 95% confidence interval -23 to 136 mL, respectively). Randomized studies tended to demonstrate no difference between ministernotomy and full sternotomy. Rate of conversion from partial to conventional sternotomy was 3.0% (95% confidence interval 1.8%-.4%).
Ministernotomy can be performed safely for aortic valve replacement, without increased risk of death or other major complication; however, few objective advantages have been shown. Surgeons must conduct well-designed, prospective studies of relevant, consistent clinical outcomes to determine the role of ministernotomy in cardiac surgery.
大多数主动脉瓣置换术采用传统的全胸骨正中切开术。部分上胸骨切开术(微创胸骨切开术)已被开发出来。
对比较微创胸骨切开术和全胸骨切开术进行主动脉瓣置换术的研究进行系统评价和荟萃分析。
选择了26项研究,共4586例主动脉瓣置换患者(2054例行微创胸骨切开术,2532例行全胸骨切开术)。死亡率无差异(比值比0.71,95%置信区间0.49 - 1.02)。微创胸骨切开术的主动脉阻断时间和体外循环时间更长(加权平均差分别为7.90分钟,95%置信区间3.50 - 10.29分钟;以及11.46分钟,95%置信区间5.26 - 17.65分钟)。微创胸骨切开术的重症监护病房住院时间和住院总时间均较短(加权平均差分别为 - 0.46天,95%置信区间 - 0.72至 - 0.20天;以及 - 0.91天,95%置信区间 - 1.45至 - 0.37天)。微创胸骨切开术的通气时间较短,24小时内失血量较少(加权平均差分别为 - 2.1小时,95%置信区间 - 2.95至 - 1.30小时;以及 - 79 mL,95%置信区间 - 23至136 mL)。随机研究倾向于表明微创胸骨切开术和全胸骨切开术之间无差异。部分胸骨切开术转为传统胸骨切开术的比例为3.0%(95%置信区间1.8% - 4.0%)。
微创胸骨切开术可安全地用于主动脉瓣置换术,不会增加死亡或其他主要并发症的风险;然而,几乎没有显示出明显的优势。外科医生必须对相关的、一致的临床结果进行精心设计的前瞻性研究,以确定微创胸骨切开术在心脏手术中的作用。